BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14477807)

  • 1. The effect of 6-mercaptopurine on the incorporation of labeled amino acids into cellular protein of chronic granulocytic leukemia leukocytes.
    NADLER SB; HANSEN HJ; SPRAGUE CC; SHERMAN H
    Blood; 1961 Sep; 18():336-43. PubMed ID: 14477807
    [No Abstract]   [Full Text] [Related]  

  • 2. Nucleic acid metabolism in leukemic human leukocytes. I. In vitro incorporation by leukocytes from chronic granulocytic leukemia.
    WILLIAMS AM
    Cancer Res; 1962 Apr; 23():314-21. PubMed ID: 14040267
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of my-leran and 6-mercaptopurine (6-MP) on the serum level of vitamin B12 in chronic myelocytic leukemia.
    DOCTOR VM; BERGSAGEL DE; SHULLENBERGER CC
    Blood; 1959 Mar; 14(3):274-8. PubMed ID: 13628825
    [No Abstract]   [Full Text] [Related]  

  • 4. Human leukocyte metabolism in vitro. II. The effect of 6-mercaptopurine on formate-C-14 incorporation into the nucleic acids of acute leukemic leukocytes.
    Scott JL; Marino JV; Gabor EP
    Blood; 1966 Nov; 28(5):683-91. PubMed ID: 5223913
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of myleran treatment on the p32 uptake of leukocytic deoxyribonucleic acid in chronic granulocytic leukemia.
    HARRISON G; LEONARD ME; LI JG
    Cancer; 1956; 9(5):963-4. PubMed ID: 13364882
    [No Abstract]   [Full Text] [Related]  

  • 6. [CHROMATOGRAPHIC STUDY OF THE FREE AMINO ACIDS IN THE BLOOD IN CHRONIC MYELOID LEUKEMIA].
    RONCHI F; GUACCI L; DEPASQUALE C
    Prog Med (Napoli); 1963 Aug; 19():484-7. PubMed ID: 14125617
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nucleic acid metabolism of leukemic leukocytes. 2. The effect of 6-mercaptopurine on nucleic acid metabolism of leukemic leukocytes].
    Kano A
    Naika Hokan; 1968 Aug; 15(8):245-53. PubMed ID: 5751146
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro thymidine uptake by circulating leukocytes.
    Sokal JE; Pauly JL
    J Lab Clin Med; 1974 Nov; 84(5):681-91. PubMed ID: 4283790
    [No Abstract]   [Full Text] [Related]  

  • 9. [The biochemistry of normal and leukemic leukocytes. II. Protein and amino acids content and metabolism].
    Sznajd J; Lisiewicz J; Pajdak W; Naskalski J
    Przegl Lek; 1969 Jun; 25(6):472-6. PubMed ID: 4898080
    [No Abstract]   [Full Text] [Related]  

  • 10. The action of 6-mercaptopurine and of triethylenemelamine on the acetylating activity of normal and leukaemic blood.
    AMBANELLI U; SALVI G; STARCICH R
    Acta Haematol; 1960 Nov; 24():267-73. PubMed ID: 13682911
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nuclear nonhistone proteins in normal and leukemic leukocytes].
    Rybakova LP
    Vopr Onkol; 1991; 37(7-8):805-12. PubMed ID: 1842633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The alkaline phosphatases of neutrophil polynuclear leukocytes in normal and pathological cases, with special reference to chronic myeloid leukemia].
    FORTEZA G; BAGUENA R; MUNOZ A; CHULIA F; CORET A
    Rev Clin Esp; 1960 Oct; 79():28-38. PubMed ID: 13700899
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nuclear proteins of human leukocytes in health and in chronic leukemias].
    Rybakova LP
    Vopr Onkol; 1993; 39(7-12):282-7. PubMed ID: 7825298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OLD AND NEW DRUGS IN THE CONTROL OF CHRONIC GRANULOCYTIC LEUKEMIA.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1964; 136():165-74. PubMed ID: 14203736
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes of the adherence capacity of the thrombus caused by leukocytes of myeloid type. Thrombelastographic research in chronic myeloid leukemia, acute uremia and reactive leukocytosis].
    WINCKELMANN G; HORDER MH
    Acta Haematol; 1957 Oct; 18(4):261-71. PubMed ID: 13487179
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated levels of the chromosomal protein HMG 17 in chronic myelogenic leukemia.
    Kondos H; Anastasiadou E; Photopoulou A; Cary P; Aleporou-Marinou V; Pataryas T
    Biochem Mol Biol Int; 1995 Jul; 36(4):803-9. PubMed ID: 8528142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free amino acids in leukocytes from normal and leukemic subjects.
    IYER GY
    J Lab Clin Med; 1959 Aug; 54():229-31. PubMed ID: 14406183
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of chronic myeloid leukaemia with mercaptopurine.
    FOUNTAIN JR
    Acta Unio Int Contra Cancrum; 1960; 16():846-8. PubMed ID: 13824163
    [No Abstract]   [Full Text] [Related]  

  • 19. DEFICIENCY OF THE HYDRAZINE SENSITIVE COMPONENT OF COMPLEMENT IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA.
    INAI S; FUJIKAWA K; MASAOKA T; TAKAHASHI H; NAGAKI K
    Biken J; 1963 Jul; 6():37-43. PubMed ID: 14147704
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of 6-mercaptopurine (6-MP) on the serum level of vitamin B12 in leukemia.
    DOCTOR VM; BERGSAGEL DE; SHULLENBERGER CC
    Clin Chim Acta; 1957 Jun; 2(3):205-9. PubMed ID: 13461306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.